Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1.
about
Analysis of the DXD motifs in human xylosyltransferase I required for enzyme activityLoss of Glycosaminoglycan Receptor Binding after Mosquito Cell Passage Reduces Chikungunya Virus InfectivityAnti-heparan sulfate peptides that block herpes simplex virus infection in vivo.Amino acid differences in glycoproteins B (gB), C (gC), H (gH) and L (gL) are associated with enhanced herpes simplex virus type-1 (McKrae) entry via the paired immunoglobulin-like type-2 receptor α.Heparan sulfate proteoglycan: an arbovirus attachment factor integral to mosquito salivary gland ducts.Bovine lactoferrin inhibits Toscana virus infection by binding to heparan sulphateSequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.Update on emerging antivirals for the management of herpes simplex virus infections: a patenting perspective.Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses.HSV trafficking and development of gene therapy vectors with applications in the nervous system.Focus on antivirally active sulfated polysaccharides: from structure-activity analysis to clinical evaluation.Phylogenetic analysis of clinical herpes simplex virus type 1 isolates identified three genetic groups and recombinant virusesBitter-sweet symphony: glycan-lectin interactions in virus biology.Phylogenetic comparison of exonic US4, US7 and UL44 regions of clinical herpes simplex virus type 1 isolates showed lack of association between their anatomic sites of infection and genotypic/sub genotypic classification.Molecular characterization of clinical isolates of herpes simplex virus type 1 collected in a tertiary-care hospital in Dublin, Ireland.
P2860
Q27983051-A0239643-9AE1-4682-9071-1628C726BA9FQ28550385-5286E4AD-B84C-4973-80B7-B363B754C81EQ33906507-E6DF896D-23BE-4A57-8226-555F38C80E53Q34281238-3E083929-EBAC-4B85-A4C3-4F9FCAAF5C30Q34774836-A6370E2D-C8AA-4B79-89A4-E440379EF427Q35159976-F9D00A48-1D85-4DB4-8ED4-D7BE65380A8EQ35220880-11D6D19F-037C-406D-9814-024A6C819470Q35531731-777B7D3F-248C-4ACE-93C4-7AF1380B934DQ35785100-31E3ED4A-B985-4C22-B9D0-D66CD2EC25DAQ36134871-5EE7554A-00F7-416B-9FE9-E54F0CA6C14CQ37278750-DEF80F1B-E654-4C76-B16F-47C254457C9DQ37511553-0347618A-52CE-4677-953C-965A86C66794Q38159719-CC96F533-0401-431B-ABEE-F6617CC02C6FQ42176895-205FF17E-5660-4095-8C3E-097364AEDCCFQ45352106-CBDF5FE1-F27E-4592-9B74-3ACF8E35D24E
P2860
Glycosaminoglycan-binding ability is a feature of wild-type strains of herpes simplex virus type 1.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Glycosaminoglycan-binding abil ...... f herpes simplex virus type 1.
@en
type
label
Glycosaminoglycan-binding abil ...... f herpes simplex virus type 1.
@en
prefLabel
Glycosaminoglycan-binding abil ...... f herpes simplex virus type 1.
@en
P2093
P50
P356
P1433
P1476
Glycosaminoglycan-binding abil ...... f herpes simplex virus type 1.
@en
P2093
Anette Roth
Elham Rekabdar
Jan-Ake Liljeqvist
P304
P356
10.1006/VIRO.2002.1639
P407
P577
2002-10-01T00:00:00Z